Company intelligence / Profile preview

Hyasen Biotechnology

Changsha, Hunan, Chinahyasen.com ↗

Ownership: Private
Development stage: Other

Overview

Hyasen Biotechnology is an active Chinese biotech specializing in supplying raw materials—including enzymes (e.g., Proteinase K), reagents for PCR/qPCR/NGS workflows, APIs for human/veterinary use, intermediates, vitamins, food additives—as well as IVD core components. They serve global clients across biopharma manufacturing and molecular diagnostics with over 1,000 products exported to more than 50 countries[1][2].

Modalities: EnzymeProtein
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Hyasen Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyasen Biotechnology.

Explore the full profile